Minerva Neurosciences transfers stock listing to Nasdaq Capital Market to avoid delisting

Minerva Neurosciences, Inc.

Transfer from Nasdaq Global Market to Nasdaq Capital Market effective Sept 12, 2022; ticker NERV unchanged.
Company was not in compliance with minimum $10M net equity requirement previously disclosed on March 8, 2022.
Nasdaq approved transfer under Listing Rule 5810(c)(3)(A); company meets all Capital Market continued listing criteria.
No impact on trading; press release issued Sept 9, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.